D. Hellenbrecht

573 total citations
36 papers, 432 citations indexed

About

D. Hellenbrecht is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, D. Hellenbrecht has authored 36 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in D. Hellenbrecht's work include Nausea and vomiting management (9 papers), Receptor Mechanisms and Signaling (6 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). D. Hellenbrecht is often cited by papers focused on Nausea and vomiting management (9 papers), Receptor Mechanisms and Signaling (6 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). D. Hellenbrecht collaborates with scholars based in Germany, Switzerland and Czechia. D. Hellenbrecht's co-authors include H. Grobecker, Björn Lemmer, Reinhard Saller, H. Balzer, I. J. Bak, D. Palm, M. Bühring, Michael S. Hildebrand, M. Hümpel and M. Gatzen and has published in prestigious journals such as Cellular and Molecular Life Sciences, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

D. Hellenbrecht

34 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Hellenbrecht Germany 12 185 95 80 62 62 36 432
C Labrid France 12 204 1.1× 88 0.9× 56 0.7× 54 0.9× 49 0.8× 35 510
Stanley W. Dziedzic United States 13 98 0.5× 65 0.7× 50 0.6× 25 0.4× 36 0.6× 23 466
A. Hayes United Kingdom 8 162 0.9× 93 1.0× 56 0.7× 133 2.1× 44 0.7× 15 599
Kanoo Hosoki Japan 11 174 0.9× 55 0.6× 100 1.3× 39 0.6× 91 1.5× 64 481
T.N. Calvey United Kingdom 15 124 0.7× 55 0.6× 119 1.5× 136 2.2× 64 1.0× 63 673
N. E. Williams United Kingdom 15 71 0.4× 50 0.5× 151 1.9× 84 1.4× 76 1.2× 41 547
Jacek Petrusewicz Poland 11 123 0.7× 64 0.7× 63 0.8× 41 0.7× 31 0.5× 48 367
William B. Wastila United States 13 225 1.2× 106 1.1× 115 1.4× 63 1.0× 88 1.4× 28 589
Philip J. Privitera United States 16 138 0.7× 126 1.3× 38 0.5× 67 1.1× 77 1.2× 38 613
Allan M. Burkman United States 14 161 0.9× 78 0.8× 24 0.3× 61 1.0× 139 2.2× 45 515

Countries citing papers authored by D. Hellenbrecht

Since Specialization
Citations

This map shows the geographic impact of D. Hellenbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Hellenbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Hellenbrecht more than expected).

Fields of papers citing papers by D. Hellenbrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Hellenbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Hellenbrecht. The network helps show where D. Hellenbrecht may publish in the future.

Co-authorship network of co-authors of D. Hellenbrecht

This figure shows the co-authorship network connecting the top 25 collaborators of D. Hellenbrecht. A scholar is included among the top collaborators of D. Hellenbrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Hellenbrecht. D. Hellenbrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gatzen, M., et al.. (2000). Analgesic Efficacy of the Serial Application of a Sulfurated Mud Bath at Home. Complementary Medicine Research. 7(5). 233–236. 10 indexed citations
2.
Beer, André-Michael, et al.. (2000). Karl und Veronica Carstens-Stiftung. Complementary Medicine Research. 7(5). 259–259. 2 indexed citations
3.
4.
Hellenbrecht, D., et al.. (1993). Minimal biliary excretion and enterohepatic recirculation of metoclopramide in patients with extrahepatic cholestasis. European Journal of Clinical Pharmacology. 45(5). 415–418. 4 indexed citations
5.
Hellenbrecht, D.. (1993). [Benefits and risks of non-steroidal anti-inflammatory drugs for systemic and local administration].. PubMed. 88(9). 532–9.
6.
Hildebrand, Michael S., et al.. (1990). Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 15(1). 19–26. 13 indexed citations
7.
Hildebrand, Michael S., et al.. (1990). Minimal biliary excretion and enterohepatic recirculation of lormetazepam in man as investigated by a new nasobiliary drainage technique.. PubMed. 28(6). 256–61. 11 indexed citations
8.
Hellenbrecht, D., et al.. (1990). Randomized placebo-controlled study with crataegus on exercise tests and challenge by catecholamines in healthy subjects. European Journal of Pharmacology. 183(2). 525–526. 6 indexed citations
9.
Hellenbrecht, D., et al.. (1987). Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver.. PubMed. 37(6). 733–6. 8 indexed citations
10.
Hellenbrecht, D. & Reinhard Saller. (1986). Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.. PubMed. 36(12). 1845–9. 7 indexed citations
11.
Saller, Reinhard, et al.. (1986). Enhancement of the Antiemetic Action of Metoclopramide Against Cisplatin‐Induced Emesis by Transdermal Electrical Nerve Stimulation. The Journal of Clinical Pharmacology. 26(2). 115–119. 9 indexed citations
12.
Saller, Reinhard, et al.. (1985). Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. European Journal of Clinical Pharmacology. 29(3). 311–312. 8 indexed citations
13.
Saller, Reinhard & D. Hellenbrecht. (1985). Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.. PubMed. 69(11). 1301–3. 16 indexed citations
14.
Hellenbrecht, D., et al.. (1984). Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat.. PubMed. 34(9). 980–3. 4 indexed citations
15.
Hellenbrecht, D. & Ludwig Gortner. (1976). Correlations between hydrophobicity and non-specific pharmacological effects of beta-adrenoceptor blocking agents.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(6). 625–30. 1 indexed citations
16.
Hellenbrecht, D., et al.. (1974). Prediction of the non-specific cardiodepressant effects of β-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis. European Journal of Pharmacology. 29(2). 223–235. 16 indexed citations
17.
Grobecker, H., et al.. (1973). Inhibition by antiarrhythmic and ?-sympatholytic drugs of serotonin uptake by human platelets: Experimentsin vitro andin vivo. European Journal of Clinical Pharmacology. 5(3). 145–150. 22 indexed citations
18.
Balzer, H. & D. Hellenbrecht. (1969). Beeinflussung des Calcium-Austauschs und der Muskelfunktion des M. rectus und sartorius des Frosches durch Chlorpromazin, Prenylamin, Imipramin und Reserpin@@@Influence of chlorpromazine, prenylamine, imipramine and reserpine on calcium exchange and muscle function (M. rectus and sartorius of frog). Naunyn-Schmiedeberg s Archives of Pharmacology. 264(2). 129–146. 18 indexed citations
19.
Balzer, H. & D. Hellenbrecht. (1969). Beeinflussung des Calcium-Austauschs und der Muskelfunktion des M. rectus und sartorius des Frosches durch Chlorpromazin, Prenylamin, Imipramin und Reserpin. Naunyn-Schmiedeberg s Archives of Pharmacology. 264(2). 129–146. 19 indexed citations
20.
Balzer, H. & D. Hellenbrecht. (1968). �ber die kontraktionsausl�sende Wirkung von Hemmstoffen des aktiven Calciumtransports (Chlorpromazin, Prenylamin, Reserpin) am Froschrectus und -sartorius. Naunyn-Schmiedeberg s Archives of Pharmacology. 260(2-3). 93–94. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Labrid Breakdown of academic impact, for papers by Stanley W. Dziedzic Breakdown of academic impact, for papers by A. Hayes Breakdown of academic impact, for papers by Kanoo Hosoki Breakdown of academic impact, for papers by T.N. Calvey Breakdown of academic impact, for papers by N. E. Williams Breakdown of academic impact, for papers by Jacek Petrusewicz Breakdown of academic impact, for papers by William B. Wastila Breakdown of academic impact, for papers by Philip J. Privitera Breakdown of academic impact, for papers by Allan M. Burkman
Rankless by CCL
2026